CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Roche and Earendil forge $1.5bn bispecific discovery deal

PartnershipPositive
AI Analysis

Summary

Roche and Earendil have entered into a $1.5 billion bispecific antibody discovery collaboration deal. The partnership combines Roche's capabilities with Earendil's bispecific technology platform.

Importance:7/10
Sentiment:
0.70
partnershipbispecificdiscoveryrocheearendil
Related Companies

Read the original article

Published by yahoo_finance on September 25, 2026 11:27 AM

Read Original